Description

BSE announces listing of Commercial Paper worth Rs. 50 crores issued by Adani Enterprises Limited on private placement basis, effective October 7, 2025.

Summary

BSE has listed new Commercial Paper issued by Adani Enterprises Limited on private placement basis. The instrument comprises 1000 units of face value Rs. 5,00,000 each, totaling Rs. 50 crores. Trading commenced on October 7, 2025 in the BSE Debt segment under scrip code 730359 (AEL061025). The paper carries CARE A1+ and ICRA A1+ ratings with maturity on March 6, 2026.

Key Points

  • 1000 units of Commercial Paper listed with face value Rs. 5,00,000 per unit
  • Total issue size: Rs. 50 crores
  • Issue price: Rs. 4,85,245 per unit (discount to face value)
  • Scrip Code: 730359, Scrip ID: AEL061025
  • ISIN: INE423A14YI2
  • Credit Rating: CARE A1+ and ICRA A1+
  • Market lot: 1 unit
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • HDFC Bank Limited acts as Issuing and Paying Agent

Regulatory Changes

No regulatory changes introduced.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE423A14YI2
  • Trading to be conducted in standard denomination of Rs. 5 lakhs and multiples
  • Tick size of 1 paise must be maintained

Important Dates

  • Allotment Date: October 6, 2025
  • Listing Date: October 7, 2025
  • Redemption Date: March 6, 2026
  • Tenure: 151 days (approximately 5 months)

Impact Assessment

Minimal market impact as this is a routine listing of short-term debt instrument on private placement basis. The commercial paper is rated A1+ by both CARE and ICRA, indicating highest safety for short-term instruments. Trading is restricted to debt segment with high minimum investment threshold (Rs. 5 lakhs), limiting participation to institutional and high net-worth investors. No impact on equity markets or retail investors.

Impact Justification

Routine commercial paper listing for established corporate issuer with no market-wide implications